The Society for Immunotherapy of Cancer’s (SITC) Fellowship Awards program was established through the Forward Fund to support the development of young investigators in the field to cultivate the next generation of cancer immunotherapy experts.
Since 2014, SITC has committed more than $2 million in fellowship awards to deserving young investigators.
TERM: One YearBEGINNING: July 2019
Conducted at the CCR in Bethesda, MD, this program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches, and also to key opinion leaders in the field of clinical immunotherapy.
TERM: One YearAMOUNT: $100,000
This cancer immunotherapy clinical fellowship award aims to provide support for an individual who has a vested interest in furthering the research and translation of immunotherapeutic approaches for treating patients with early stage NSCLC.
Sponsored byMade possible by an educational grant from AstraZeneca Pharmaceuticals LP.
This fellowship award is named after Holbrook Kohrt, MD, PhD, assistant professor at the Stanford University School of Medicine, renowned for his clinical trials research examining novel immunologic approaches and his translational research on novel therapies to enhance anti-tumor immunity. Dr. Kohrt was a member of the Levy Laboratory, which helped develop and test the first U.S. Food and Drug Administration (FDA)-approved antibody against cancer for the treatment of lymphoma in 1997. He started his own laboratory in 2012, and helped develop five novel patented approaches to cancer immunotherapy
Made possible by an educational grant from Genentech
Interested in supporting a fellowship? Contact SITC Development at firstname.lastname@example.org or +1 414-271-2456.
Also, visit our Frequently Asked Questions page for more details about the SITC Fellowship Awards.
Looking to view past recipients of SITC Fellowship Awards? Click the links below:
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com